CV Sciences Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
44
- Stock Symbol
-
CVSI
- Investments
-
5
CV Sciences General Information
Description
CV Sciences Inc is a consumer wellness company specializing in nutraceuticals and plant-based foods products. It develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol. The company sells its products under tradenames, such as +PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox. The company's products are sold in a variety of market sectors, including nutraceutical, beauty care, and specialty foods. The company has one operating segment, which is the business of hemp-based CBD wellness products. Geographically, all of the company's revenue is generated from United States. The company also operates a drug development program focused on developing and commercializing CBD-based novel therapeutics.
Contact Information
Website
www.cvsciences.comCorporate Office
- 9530 Padgett Street
- Suite 107
- San Diego, CA 92126
- United States
Corporate Office
- 9530 Padgett Street
- Suite 107
- San Diego, CA 92126
- United States
CV Sciences Stock Performance
As of 13-Nov-2026, CV Sciences’s current market cap is $2.03M with 226M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.03M | 226M | 699K | -$0.01 |
CV Sciences Financials Summary
As of 30-Jun-2026, CV Sciences has a trailing 12-month revenue of $12.7M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 6,138 | 12,297 | 6,084 | 4,291 |
| Revenue | 12,743 | 13,789 | 15,705 | 16,004 |
| EBITDA | (1,572) | (240) | (1,856) | 3,331 |
| Net Income | (2,006) | (958) | (2,394) | 3,102 |
| Total Assets | 6,521 | 6,962 | 7,927 | 9,200 |
| Total Debt | 1,253 | 1,609 | 779 | 442 |
CV Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CV Sciences Comparisons
Industry
Financing
Details
CV Sciences Competitors (1)
One of CV Sciences’s competitors is Charlotte's Web, a Formerly VC-backed company based in Louisville, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Charlotte's Web | Formerly VC-backed | Louisville, CO |
CV Sciences Patents
CV Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2017267927-A1 | Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction | Active | 16-May-2016 | ||
| AU-2017267927-B2 | Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction | Inactive | 16-May-2016 | ||
| AU-2020256349-A1 | Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction | Active | 16-May-2016 | ||
| AU-2020256349-B2 | Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction | Inactive | 16-May-2016 | ||
| CA-3021835-A1 | Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction | Active | 16-May-2016 | A61K31/658 |
CV Sciences Signals
CV Sciences Investments & Acquisitions (5)
CV Sciences’s most recent deal was a Merger/Acquisition with Extract Labs for . The deal was made on 21-Nov-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Extract Labs | 21-Nov-2024 | Merger/Acquisition | Other Consumer Non-Durables | ||
| Elevated Softgels | 13-May-2024 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Cultured Foods | 07-Dec-2023 | Merger/Acquisition | Food Products | ||
| CanX (Drug Discovery) | 04-Jan-2016 | Merger/Acquisition | Drug Discovery | ||
| Neuropathix | 07-Mar-2013 | Early Stage VC | Drug Discovery |
CV Sciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Household Products
Industry
Rank
Percentile
Personal Products
Subindustry
Rank
Percentile
CV Sciences Exits (1)
CV Sciences’s most recent exit was on 07-Mar-2013 from Neuropathix. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Neuropathix | 07-Mar-2013 | Completed |
|
CV Sciences Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cultured Foods | Puławy, Poland | 2019 | |
| Elevated Softgels | Grand Junction, CO | 2019 |
CV Sciences FAQs
-
When was CV Sciences founded?
CV Sciences was founded in 2010.
-
Where is CV Sciences headquartered?
CV Sciences is headquartered in San Diego, CA.
-
What is the size of CV Sciences?
CV Sciences has 44 total employees.
-
What industry is CV Sciences in?
CV Sciences’s primary industry is Drug Discovery.
-
Is CV Sciences a private or public company?
CV Sciences is a Public company.
-
What is CV Sciences’s stock symbol?
The ticker symbol for CV Sciences is CVSI.
-
What is the current market cap of CV Sciences?
The current market capitalization of CV Sciences is $2.03M.
-
What is CV Sciences’s current revenue?
The trailing twelve month revenue for CV Sciences is $12.7M.
-
Who are CV Sciences’s competitors?
Charlotte's Web is a competitor of CV Sciences.
-
What is CV Sciences’s annual earnings per share (EPS)?
CV Sciences’s EPS for 12 months was -$0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process